- Article
Factors Associated with GLP-1 Receptor Agonist Use in Patients with Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Retrospective Propensity-Score Matched Analysis
- Georgios Vournas,
- Leonidas Mourgos,
- Michael Doumas,
- Evangelos N. Liberopoulos,
- Kalliopi Kotsa and
- Theocharis Koufakis
17 February 2026
Background: Atherosclerotic cardiovascular disease (ASCVD) frequently coexists with type 2 diabetes (T2D), amplifying morbidity and mortality. Glucagon-like peptide-1 receptor agonists (GLP-1RA) confer significant cardiovascular benefits and are reco...

